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Introduction: There are many different causes of pulmonary hypertension and the pathogenesis of the
disease is still being elucidated. Although they are not the most common, autoimmunity and inﬂam-
mation have been identiﬁed as possible causes. No one autoantibody has been identiﬁed as the deﬁnite
cause of pulmonary hypertension. We present a rare association of anti-SSA/Ro antibodies and isolated
pulmonary hypertension.
Case presentation: A 53 year old African American female presented with abdominal pain, nausea, weight
loss, dyspnea and fatigue. Upon further exam she was found to have high titers of antinuclear antibodies
and anti-SSA/Ro antibodies. This antibody proﬁle would typically be suggestive of Sj€ogren's Syndrome,
which is characterized by dry eyes and poor salivary gland function. However, since this patient did not
have any symptoms consistent with the disease a diagnosis of Sj€ogren's Syndrome could not be made. A
combination of laboratory, imaging and diagnostic studies were done that revealed a ﬁnal diagnosis of
pulmonary hypertension.
Conclusion: It is known that pulmonary hypertension has association with autoimmune diseases,
however no clear markers yet exist. Anti-SSA/Ro antibodies have been rarely described in cases of
pulmonary disease, and less so in pulmonary hypertension. This case describes a unique association
between isolated pulmonary hypertension and anti-SSA/Ro antibody, thereby illustrating the need to
investigate this autoantibody and others in the pathogenesis of autoimmune pulmonary hypertension.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Pulmonary hypertension (PH) is a rare disease and its cause has
yet to be elucidated. However, multiple studies have suggested an
autoimmune component to the development of PH. Here is
described a case of a patient with PH and positive antinuclear an-
tibodies (ANA) and anti-SSA/Ro titers without associated Sj€ogren's
Syndrome (SS). Anti-SSA/Ro antibodies have been described in
pulmonary disease in the literature, but rarely in pulmonary hy-
pertension. This case is a rare presentation of PH in conjunction
with otherwise asymptomatic elevated ANA and anti-SSA/Ro
antibodies.. Guerreso), Conner_ea@med.
Ltd. This is an open access article u2. Case report
A 53 year old African American female presented to the emer-
gency center complaining of a two day history of nausea and right
upper quadrant pain. She stated that she experiencedweight loss in
the last year and a three year history of dyspnea with increasing
fatigue. She attributed her weight loss to the difﬁculty of simulta-
neous eating and breathing. She denied dry mouth, dry eyes, he-
moptysis, and epistaxis. She denied current and past tobacco,
alcohol and illicit drug use. She had not seen a primary care
physician regularly due to ﬁnancial circumstances.
The physical exam was signiﬁcant for a cachectic appearance,
temporal wasting, digital clubbing in all ﬁngers on the left hand and
ﬁfth ﬁnger on the right, and xerosis on her lower extremities. Labs
revealed hyponatremia, leukopenia, thrombocytopenia, macrocytic
anemia, elevated liver enzymes, hyperproteinemia and hypo-
albuminemia. Hepatitis B, C, and HIV tests were negative, B12,
folate and TSH levels were within normal limits. ESR and CRP were
elevated. An autoantibody panel was strongly positive for ANA andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Protein levels were elevated and a serum protein electropho-
resis showed hypoalbuminemia and diffuse polyclonal hyper-
gammaglobulinemia suggestive of chronic inﬂammation or
autoimmune disease. Urine protein electrophoresis was insigniﬁ-
cant. AP chest x-ray showed suspicion of emphysematous change in
the upper lungs without inﬁltrates or effusions and cardiac
enlargement. A thorax CT with contrast showed a faint right upper
lobe subpleural peripheral groundglass opaciﬁcation measuring
11  6.5 mm, and a soft tissue density left lung base likely atelec-
tasis and/or partial consolidation Fig. 1.
An echocardiogram showed the right ventricle (RV) and right
atrium (RA) both to be mildly dilated, RV systolic pressure esti-
mated to be 60e65 mmHg, moderate tricuspid regurgitation, mild
to moderate pulmonic valvular regurgitation, and no deﬁnite evi-
dence of ASD or PFO. A right heart catheterization showed primary
pulmonary hypertension. Pulmonary artery (PA) pressure was 50/
25 with a mean of 36. RV pressure was 50/9 with an EDP of 10. RA
pressure mean of 9. RA saturation 73%, PA sat 70% and aortic
saturation 90%. Pulmonary vascular resistance: 5.81 Woods. Fick
cardiac output: 4.13 with a cardiac index of 2.91.3. Discussion
This case uniquely describes a patient with an antibody proﬁle
consistent with SS, yet devoid of a clinical picture that would
complete the diagnosis. This patient was also found to have pri-
mary pulmonary hypertension with resulting right heart disease.
This case represents a need to identify the anti-SSA/Ro IgG antibody
as a possible pathogenic autoantibody in lung disease, and more
speciﬁcally PH. There have been other associations of lung disease
and PH with this autoantibody and will be further discussed here.
PH is deﬁned as pulmonary artery pressure 25 mmHg in the
setting of normal or reduced cardiac output with a normal capillary
wedge pressure [1]. Manymechanisms of injury are described, each
with the end result of elevated pressures in the pulmonary vascu-
lature. Some mechanisms, such as the BMPR2 mutation, cause
proliferation of the pulmonary vascular smooth muscle cells [1].
Others affect the endothelial cells of the vasculature or the autor-
egulation of the pulmonary vasculature [1]. Other causes include
proinﬂammatory and procoaguable states [1].
The diagnosis of SS is made when certain laboratory and clinical
criteria are met. Positive laboratory ﬁndings include: antibodies to
SSA/Ro and/or SSB/La antigens and salivary gland histopathologyFig. 1. Faint right upper lobe subpleural peripheral groundglass opaciﬁcation 11  6.5 mm aconsistent with focal lymphocytic sialoadenitis [2]. Clinical criteria
include xerostomia and/or xeropthalmia in the absence of another
possible cause, or diagnostic studies such as parotid sialography
and salivary sctinography that display subfunctional glandular
structures [2]. This patient had an antibody panel that would be
consistent with SS, however she lacked any glandular symptoms,
thus making this diagnosis incomplete. It is possible to primarily
display extraglandular symptoms with SS [2], however PH has only
rarely been described in SS [3].
The relationship between PH and autoimmune diseases has long
been recognized, frequently described in systemic scleroderma and
SLE [4], but the pathogenesis is unknown. It is not known whether
the inﬂammation present in PH is a cause or consequence of PH [4].
A relationship between dysregulation of CD4þ T cells and
CD4þ25 þ Treg cells has been identiﬁed4. There have been cases of
PH citing the pathogenic activation of autoreactive B and T cells in
the face of this dysfunction [3,4].
No single autoantibody has been identiﬁed as the cause of the
damage in PH, but many have been associated with the disease. A
review of a small number of cases of primary SS patients with PH
showed that antinuclear, anti-SSA/Ro, anti-RNP, positive rheuma-
toid factor and hypergammaglobinemia were more common in
these patients than in primary SS patients without PH [3]. Although
many patients with autoimmune diseases have a positive ANA titer,
studies have shown that the prevalence of positive ANA titers in PH
patients is equal to that of the population without PH, thus making
ANA a less likely candidate for a cause of PH. A 1989 study in India
of clinical correlations with antibodies to extractable nuclear anti-
gens was the ﬁrst to ﬁnd an association between anti-SSA/Ro an-
tibodies and PH [5]. Another study looked at the prevalence of a
variety of autoantibodies in the blood of patients with primary PH
(PPH) and found anti-Ku antibodies to be most signiﬁcantly a
suggestive of a marker for PH, although they also saw anti-CENP-B,
anti-topoisomerase I, anti-SSA/Ro and anti-SSB/La autoantibodies
in PPH patients [6]. A study of cardiac involvement in SLE patients
determined that 18.2% of patients with anti-SSA/Ro antibodies had
PH [7].
Anti-SSA/Ro antibodies have been seen in patients with lung
disease. A case report demonstrated a patient with toxic epidermal
necrolysis (TEN) who unusually suffered from chronic pulmonary
complications after the resolution of his disease and was also found
to be asymptomatically positive for anti-SSA/Ro antibody at the
onset of TEN [8]. Another researcher discovered that in patients
with antisynetase syndrome, the presence of anti-SSA/Rond soft tissue density in the left lung base likely atelectasis and/or partial consolidation.
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ease [9]. A case was reported in Japan of pulmonary ﬁbrosis in a
anti-SSA/Ro positive and ANA negative patient without lupus [10].
The relationship between these cases and our own shows a rela-
tionship between anti-SSA/Ro antibodies and chronic inﬂammation
and destruction of pulmonary structures, thus making a case for a
target of these antibodies in the lungs.
4. Conclusion
This is a unique case of PH associated with antieSSeA/Ro anti-
bodies in the absence of clinical signs of SS. Although there is an
association between autoimmunity and inﬂammation with PH, the
association with anti-SSA/Ro autoantibodies and PH is quite rare.
Since this is only a single case a deﬁnite association cannot yet be
established to support the involvement of anti-SSA/Ro antibodies in
the pathogenesis of lung disease and PH. However, this case high-
lights the potential for further evaluation of anti-SSA/Ro antibodies
as a possible PH marker.
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